Design, synthesis and evaluation of phenethylaminoheterocycles as Kv1.5 inhibitors
摘要:
Phenethylaminoheterocycles have been prepared and assayed for inhibition of the K(v)1.5 potassium ion channel as a potential approach to the treatment of atrial fibrillation. A diverse set of heterocycles were identified as potent K(v)1.5 inhibitors and were advanced to pharmacodynamic evaluation based on selectivity and pharmacokinetic profile. Heterocycle optimization and template modification lead to the identification of compound 24 which demonstrated increased atrial effective refractory period in the rabbit pharmacodynamic model with mild effects on blood pressure and heart rate. (C) 2014 Elsevier Ltd. All rights reserved.
A compound of formula I
wherein R
1
, R
2
, R
3
, R
4
and R
5
are described herein.
化合物I的公式如下,其中R1、R2、R3、R4和R5的描述如下。
US7915410B2
申请人:——
公开号:US7915410B2
公开(公告)日:2011-03-29
US8357809B2
申请人:——
公开号:US8357809B2
公开(公告)日:2013-01-22
[EN] ACYCLIC IKUR INHIBITORS<br/>[FR] INHIBITEURS D'IKUR ACYCLIQUES
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2007030582A2
公开(公告)日:2007-03-15
[EN] A compound of formula I wherein R1, R2, R3, R4 and R5 are described herein. [FR] Composé représenté par la formule I dans laquelle R1, R2, R3, R4 et R5 correspondent à leur signification dans le descriptif.